The DYSF Gene Limb-Girdle Muscular Dystrophy Autosomal Recessive Type 2B Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the DYSF gene. This gene is crucial for the proper functioning of muscles, and mutations can lead to Limb-Girdle Muscular Dystrophy Type 2B (LGMD2B), a condition characterized by progressive weakness and wasting of the limb-girdle muscles, which are those around the hips and shoulders. LGMD2B is an autosomal recessive disorder, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected.
The test involves analyzing the patient's DNA, usually extracted from a blood sample, to detect any abnormalities in the DYSF gene. This genetic testing is essential for confirming the diagnosis of LGMD2B, understanding the risk of passing the disorder to future generations, and making informed decisions about management and treatment options.
The cost of the DYSF Gene Limb-Girdle Muscular Dystrophy Autosomal Recessive Type 2B Genetic Test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis required to identify the specific mutations in the DYSF gene that are responsible for the condition. Early diagnosis through this test can be crucial for the timely initiation of supportive therapies and interventions to manage symptoms and improve the quality of life for affected individuals.
The SGCG gene plays a crucial role in the development and function of muscles in the body. Mutations in this gene can lead to a condition known as limb-girdle muscular dystrophy type 2C (LGMD2C), which is an autosomal recessive disorder. This means that an individual must inherit two copies of the mutated gene, one from each parent, to be affected by the condition. LGMD2C primarily affects the voluntary muscles around the hips and shoulders (the limb-girdle muscles), leading to progressive weakness and wasting of these muscle groups.
Genetic testing for mutations in the SGCG gene is a critical step in diagnosing LGMD2C. This test can confirm the presence of mutations in the gene, helping in the diagnosis and management of the condition. At DNA Labs UAE, individuals can undergo the SGCG gene test, which is a sophisticated genetic analysis aimed at identifying mutations associated with limb-girdle muscular dystrophy type 2C.
The cost of the SGCG gene test at DNA Labs UAE is 4400 AED. This test is conducted with high precision and accuracy, utilizing advanced genetic sequencing technologies to detect mutations in the SGCG gene. By opting for this test, patients and their families can gain valuable insights into the genetic basis of their condition, enabling them to make informed decisions about treatment and management options.
The SGCA gene plays a crucial role in the development and function of muscles in the human body. Mutations in the SGCA gene can lead to Limb-girdle muscular dystrophy type 2D (LGMD2D), which is an autosomal recessive disorder. This condition is characterized by progressive weakness and wasting of the limb-girdle muscles, which are the muscles around the shoulders and hips. Early symptoms often include difficulty running or climbing stairs, and the condition can progressively lead to more severe muscle weakness.
To diagnose this specific type of muscular dystrophy, genetic testing is utilized to identify mutations in the SGCA gene. At DNA Labs UAE, a specialized test for the SGCA gene Limb-girdle muscular dystrophy autosomal recessive type 2D is available. This test is crucial for confirming the diagnosis, understanding the progression of the disease, and making informed decisions about management and treatment options.
The cost of the SGCA gene Limb-girdle muscular dystrophy autosomal recessive type 2D genetic test at DNA Labs UAE is 4400 AED. This test is a vital resource for individuals experiencing symptoms of limb-girdle muscular dystrophy, as well as for families with a history of the condition, as it provides essential genetic information that can aid in diagnosis and future planning.
The SGCB gene is associated with limb-girdle muscular dystrophy type 2E (LGMD2E), a genetic condition characterized by progressive muscle weakness and atrophy, particularly affecting the hip and shoulder muscles. This condition is inherited in an autosomal recessive manner, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected.
The genetic test for LGMD2E specifically examines the SGCB gene for mutations known to cause the disorder. This test is crucial for accurate diagnosis, enabling targeted treatment and management strategies, and providing valuable information for family planning.
At DNA Labs UAE, the test for SGCB gene mutations associated with limb-girdle muscular dystrophy autosomal recessive type 2E is offered at a cost of 4400 AED. The testing process involves collecting a DNA sample, typically through a blood draw or cheek swab, and analyzing the genetic material for specific mutations in the SGCB gene. Results from this test can help confirm a diagnosis of LGMD2E, guide treatment decisions, and provide important information for genetic counseling.
The TCAP Gene Limb-Girdle Muscular Dystrophy autosomal recessive type 2G (LGMD2G) Genetic Test is a specialized diagnostic evaluation available at DNA Labs UAE, designed to identify mutations in the TCAP gene. These mutations are responsible for causing Limb-Girdle Muscular Dystrophy type 2G, a rare genetic disorder characterized by progressive weakness and wasting of the limb muscles as well as the muscles around the hips and shoulders (the limb-girdle area). This condition is inherited in an autosomal recessive pattern, meaning that an individual must receive a defective gene from each parent to be affected.
The test is crucial for accurate diagnosis, enabling early intervention and management of the condition. It involves analyzing the patient's DNA to look for specific genetic alterations in the TCAP gene that are indicative of LGMD2G. By identifying the genetic underpinnings of the disease, healthcare providers can offer targeted advice on treatment options and genetic counseling for affected families.
The cost of the TCAP Gene Limb-Girdle Muscular Dystrophy autosomal recessive type 2G Genetic Test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis required to detect the presence of the specific gene mutations associated with the condition, providing essential information for affected individuals and their families regarding the prognosis and potential management strategies for LGMD2G.
The TRIM32 gene limb-girdle muscular dystrophy autosomal recessive type 2H genetic test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the TRIM32 gene. These mutations are responsible for causing limb-girdle muscular dystrophy type 2H (LGMD2H), a condition characterized by progressive weakness and wasting of the muscles around the hips and shoulders. This form of muscular dystrophy is inherited in an autosomal recessive pattern, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to develop the condition.
The test involves analyzing the patient's DNA to search for specific genetic alterations in the TRIM32 gene that are known to cause LGMD2H. Early diagnosis through genetic testing is crucial for managing symptoms, implementing appropriate treatment plans, and providing genetic counseling for affected families.
DNA Labs UAE offers this comprehensive genetic test for a cost of 4400 AED. The test is conducted in a state-of-the-art laboratory setting by a team of expert geneticists and technicians, ensuring accurate and reliable results. Patients opting for this test can expect a thorough analysis of the TRIM32 gene, which will aid in confirming a diagnosis of limb-girdle muscular dystrophy type 2H, potentially guiding treatment decisions and helping to assess the risk of passing the condition on to future generations.
The FKRP gene limb-girdle muscular dystrophy autosomal recessive type 2I genetic test is a specialized diagnostic tool designed to detect mutations in the FKRP gene, which are responsible for causing limb-girdle muscular dystrophy type 2I (LGMD2I). This form of muscular dystrophy is characterized by progressive muscle weakness and wasting, primarily affecting the muscles around the hips and shoulders (the limb-girdle area). It is inherited in an autosomal recessive manner, meaning that two copies of the defective gene, one from each parent, are required for the condition to manifest.
The test involves analyzing the patient's DNA, extracted from a blood sample, to identify mutations in the FKRP gene that are linked to LGMD2I. This genetic test is crucial for accurate diagnosis, allowing for early intervention, management plans, and genetic counseling for affected families. It also helps in distinguishing LGMD2I from other forms of muscular dystrophy and related disorders.
Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test is priced at 4400 AED. DNA Labs UAE is equipped with state-of-the-art technology and staffed by experts in genetic analysis, ensuring high-quality testing and reliable results. This test is an essential resource for individuals exhibiting symptoms of limb-girdle muscular dystrophy, as well as for their families seeking to understand their genetic health and risks.
The TTN gene limb-girdle muscular dystrophy autosomal recessive type 2J genetic test is a specialized diagnostic tool designed to identify mutations in the TTN gene, which are responsible for causing limb-girdle muscular dystrophy type 2J (LGMD2J). This form of muscular dystrophy is characterized by progressive weakness and wasting of the limb-girdle muscles, which include the shoulders and hips. It is an autosomal recessive condition, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to develop the disease.
DNA Labs UAE offers this genetic test, providing a crucial service for individuals and families seeking to understand their genetic status in relation to LGMD2J. The test involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then analyzed in the laboratory for the presence of specific mutations in the TTN gene.
The cost of the TTN gene limb-girdle muscular dystrophy autosomal recessive type 2J genetic test at DNA Labs UAE is 4400 AED. This cost covers the full process of the test, from sample collection to genetic analysis and reporting of results. The results from this test can provide valuable information for affected individuals and their families, including the confirmation of a diagnosis, insights into the prognosis of the disease, and guidance for genetic counseling and family planning.
The POMT1 gene limb-girdle muscular dystrophy autosomal recessive type 2K genetic test is a specialized diagnostic tool designed to identify mutations in the POMT1 gene, which are responsible for causing limb-girdle muscular dystrophy type 2K (LGMD2K). This form of muscular dystrophy is characterized by progressive weakness and wasting of the muscles around the hips and shoulders (the limb-girdle area), often leading to difficulties with mobility and daily activities. The condition is inherited in an autosomal recessive manner, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected.
The test is available at DNA Labs UAE, a leading facility in genetic diagnostics and research. The cost of the test is 4400 AED, and it involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory for the presence of mutations in the POMT1 gene. This genetic test is crucial for accurate diagnosis, allowing for better management and treatment planning for individuals affected by LGMD2K. It can also provide valuable information for family planning and genetic counseling for families affected by this condition.
The ANO5 gene limb-girdle muscular dystrophy autosomal recessive type 2L (LGMDR2, formerly LGMD2L) genetic test is a specialized diagnostic tool offered by DNA Labs UAE, aimed at identifying mutations in the ANO5 gene that are associated with this specific form of muscular dystrophy. Limb-girdle muscular dystrophy is a group of genetic disorders characterized by progressive muscle weakness and atrophy, primarily affecting the muscles around the hips and shoulders (the limb-girdle area). The autosomal recessive type 2L variant, associated with mutations in the ANO5 gene, is one of the many subtypes of this condition.
The test, which costs 4400 AED, involves analyzing the patient's DNA to detect mutations in the ANO5 gene that are known to cause LGMDR2. It is a crucial step for patients showing symptoms of muscular dystrophy, as a definitive genetic diagnosis can help in understanding the progression of the disease, inform treatment options, and allow for genetic counseling for the family. Conducted at DNA Labs UAE, this test is an important resource for individuals and families seeking answers about this specific form of limb-girdle muscular dystrophy.
